home > pmps > winter 2016 > see and be seen
Pharmaceutical Manufacturing and Packing Sourcer

See and Be Seen

Respiratory Drug Delivery (RDD®) 2016 will be held at the Westin Kierland Resort and Spa in Phoenix, Arizona from 17-21 April 2016.
It offers attendees a unique opportunity to participate in the best international conference of its kind, featuring in-depth presentations and discussions of pioneering respiratory drug delivery science in tandem with expanded opportunities for networking.


• In-depth discussions of developing issues surrounding combination product design and crossover technologies that connect with the diverse expertise of delegates from the drug delivery industry
• Scientific Poster Session and Technology Exhibition, during which device and equipment designers and component suppliers showcase their latest developments alongside scientific posters from the aerosol community
• Posters on the Podium, where innovative poster abstracts are presented as short podium presentations during a special session in the main auditorium
• The Charles G Thiel Award will be given to a scientist who has pioneered significant developments in the area of respiratory drug delivery
• RDD 2016 peer-reviewed proceedings will be published and made available electronically to all registrants free of charge
• A coordinated symposium with the International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS) relating to ‘Meeting the quality challenge for orally inhaled drug products’ takes place after the meeting


Registration is currently open at
Students and employees of academic and government agencies can benefit from a special discount.

Podium speakers have all already been decided on for RDD 2016, however we welcome submission of talk titles and speaker nominations for podium presentations at RDD Asia 2016 (deadline 1 March) and RDD Europe 2017 (deadline 1 August). Potential speakers who can offer novel data and insights are invited to submit a 200-word summary of their purpose and major findings to the Organising Committee ( Each summary will be reviewed for originality, merit, and ‘program fit’ before invitations are sent.

Companies are invited to participate in the Technology Exhibition at RDD 2016. Tables are provided so that companies may display components, excipients, hardware or services relevant to inhaled pharmaceutical products. The Technology Exhibition and Scientific Poster Session will be continuously accessible during meeting hours through Tuesday 19 April. Details and sign up – on a first-come first-served basis – are available at The meeting homepage contains many more details, including sponsorship opportunities and details of the Charles G Thiel Award.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:

There are no comments in regards to this article.


Print this page
Send to a friend
Privacy statement
News and Press Releases

CPI to showcase results from BioStreamline project developing novel biotherapeutics

CPI, a UK-based technology innovation centre and a founding member of the High Value Manufacturing Catapult, announced today that it will host an event in Darlington, UK on 26 June 2019 to disseminate the results of the £11.2M BioStreamline project to optimise the development of novel therapeutics. During the event, the project partners — Lonza Biologics, UCB Celltech, Sphere Fluidics, Horizon Discovery Group plc (Horizon), Alcyomics Ltd and CPI — will showcase the results and discuss the potential impact on overcoming some of the most significant shortcomings of the biologics supply chain.
More info >>

White Papers

Mouse Models for Evaluation of Vaccines and Therapeutics Against Staphylococcal Infections

IBT Bioservices

Introduction Staphylococcus aureus (SA) is a ubiquitous, formidable Gram-positive pathogen associated with skin and soft tissue, as well as lifethreatening systemic infections. SA is a leading cause of hospital- and community-associated infections worldwide, affecting humans and animals. The wide range of pathologies reflects the diverse abilities of this microbe to escape the innate and adaptive immune response using virulence factors. Since its first emergence in the 1960s methicillin-resistant SA (MRSA) has become endemic in hospitals and healthcare settings worldwide. In the 1990s, community associated MRSA strains (CA-MRSA) emerged, and are spreading worldwide posing a major global challenge.
More info >>

Industry Events



SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>



©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement